These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

2060 related items for PubMed ID: 18163430

  • 1. TGF-beta signaling and androgen receptor status determine apoptotic cross-talk in human prostate cancer cells.
    Zhu ML, Partin JV, Bruckheimer EM, Strup SE, Kyprianou N.
    Prostate; 2008 Feb 15; 68(3):287-95. PubMed ID: 18163430
    [Abstract] [Full Text] [Related]

  • 2. Restoration of transforming growth factor beta signaling pathway in human prostate cancer cells suppresses tumorigenicity via induction of caspase-1-mediated apoptosis.
    Guo Y, Kyprianou N.
    Cancer Res; 1999 Mar 15; 59(6):1366-71. PubMed ID: 10096572
    [Abstract] [Full Text] [Related]

  • 3. Androgen receptor and TGFbeta1/Smad signaling are mutually inhibitory in prostate cancer.
    van der Poel HG.
    Eur Urol; 2005 Dec 15; 48(6):1051-8. PubMed ID: 16257107
    [Abstract] [Full Text] [Related]

  • 4. Bcl-2 antagonizes the combined apoptotic effect of transforming growth factor-beta and dihydrotestosterone in prostate cancer cells.
    Bruckheimer EM, Kyprianou N.
    Prostate; 2002 Oct 01; 53(2):133-42. PubMed ID: 12242728
    [Abstract] [Full Text] [Related]

  • 5. Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence.
    Unni E, Sun S, Nan B, McPhaul MJ, Cheskis B, Mancini MA, Marcelli M.
    Cancer Res; 2004 Oct 01; 64(19):7156-68. PubMed ID: 15466214
    [Abstract] [Full Text] [Related]

  • 6. Interruption of nuclear factor kappaB signaling by the androgen receptor facilitates 12-O-tetradecanoylphorbolacetate-induced apoptosis in androgen-sensitive prostate cancer LNCaP cells.
    Altuwaijri S, Lin HK, Chuang KH, Lin WJ, Yeh S, Hanchett LA, Rahman MM, Kang HY, Tsai MY, Zhang Y, Yang L, Chang C.
    Cancer Res; 2003 Nov 01; 63(21):7106-12. PubMed ID: 14612503
    [Abstract] [Full Text] [Related]

  • 7. Synergistic activation of the androgen receptor by bombesin and low-dose androgen.
    Dai J, Shen R, Sumitomo M, Stahl R, Navarro D, Gershengorn MC, Nanus DM.
    Clin Cancer Res; 2002 Jul 01; 8(7):2399-405. PubMed ID: 12114445
    [Abstract] [Full Text] [Related]

  • 8. Modulation of sensitivity to transforming growth factor-beta 1 (TGF-beta 1) and the level of type II TGF-beta receptor in LNCaP cells by dihydrotestosterone.
    Kim IY, Zelner DJ, Sensibar JA, Ahn HJ, Park L, Kim JH, Lee C.
    Exp Cell Res; 1996 Jan 10; 222(1):103-10. PubMed ID: 8549651
    [Abstract] [Full Text] [Related]

  • 9. GCP-mediated growth inhibition and apoptosis of prostate cancer cells via androgen receptor-dependent and -independent mechanisms.
    Tepper CG, Vinall RL, Wee CB, Xue L, Shi XB, Burich R, Mack PC, de Vere White RW.
    Prostate; 2007 Apr 01; 67(5):521-35. PubMed ID: 17252539
    [Abstract] [Full Text] [Related]

  • 10. Overexpression of transforming growth factor (TGF) beta1 type II receptor restores TGF-beta1 sensitivity and signaling in human prostate cancer cells.
    Guo Y, Kyprianou N.
    Cell Growth Differ; 1998 Feb 01; 9(2):185-93. PubMed ID: 9486855
    [Abstract] [Full Text] [Related]

  • 11. The conventional transforming growth factor-beta (TGF-beta) receptor type I is not required for TGF-beta 1 signaling in a human prostate cancer cell line, LNCaP.
    Kim IY, Zelner DJ, Lee C.
    Exp Cell Res; 1998 May 25; 241(1):151-60. PubMed ID: 9633523
    [Abstract] [Full Text] [Related]

  • 12. Down-regulation of transforming growth factor beta receptors by androgen in ovarian cancer cells.
    Evangelou A, Jindal SK, Brown TJ, Letarte M.
    Cancer Res; 2000 Feb 15; 60(4):929-35. PubMed ID: 10706107
    [Abstract] [Full Text] [Related]

  • 13. Activation of p300 histone acetyltransferase activity and acetylation of the androgen receptor by bombesin in prostate cancer cells.
    Gong J, Zhu J, Goodman OB, Pestell RG, Schlegel PN, Nanus DM, Shen R.
    Oncogene; 2006 Mar 30; 25(14):2011-21. PubMed ID: 16434977
    [Abstract] [Full Text] [Related]

  • 14. Functional localization and competition between the androgen receptor and T-cell factor for nuclear beta-catenin: a means for inhibition of the Tcf signaling axis.
    Mulholland DJ, Read JT, Rennie PS, Cox ME, Nelson CC.
    Oncogene; 2003 Aug 28; 22(36):5602-13. PubMed ID: 12944908
    [Abstract] [Full Text] [Related]

  • 15. Vasoactive intestinal peptide transactivates the androgen receptor through a protein kinase A-dependent extracellular signal-regulated kinase pathway in prostate cancer LNCaP cells.
    Xie Y, Wolff DW, Lin MF, Tu Y.
    Mol Pharmacol; 2007 Jul 28; 72(1):73-85. PubMed ID: 17430995
    [Abstract] [Full Text] [Related]

  • 16. Dihydrotestosterone interacts with EGFR/MAPK signalling and modulates EGFR levels in androgen receptor-positive LNCaP prostate cancer cells.
    Mukherjee B, Mayer D.
    Int J Oncol; 2008 Sep 28; 33(3):623-9. PubMed ID: 18695894
    [Abstract] [Full Text] [Related]

  • 17. 5alpha-androstane-3alpha,17beta-diol supports human prostate cancer cell survival and proliferation through androgen receptor-independent signaling pathways: implication of androgen-independent prostate cancer progression.
    Yang Q, Titus MA, Fung KM, Lin HK.
    J Cell Biochem; 2008 Aug 01; 104(5):1612-24. PubMed ID: 18320593
    [Abstract] [Full Text] [Related]

  • 18. Androgen receptor signaling and vitamin D receptor action in prostate cancer cells.
    Murthy S, Agoulnik IU, Weigel NL.
    Prostate; 2005 Sep 01; 64(4):362-72. PubMed ID: 15754350
    [Abstract] [Full Text] [Related]

  • 19. Blockade of transforming growth factor-beta signaling suppresses progression of androgen-independent human prostate cancer in nude mice.
    Zhang F, Lee J, Lu S, Pettaway CA, Dong Z.
    Clin Cancer Res; 2005 Jun 15; 11(12):4512-20. PubMed ID: 15958637
    [Abstract] [Full Text] [Related]

  • 20. Androgen up-regulates epidermal growth factor receptor expression and binding affinity in PC3 cell lines expressing the human androgen receptor.
    Brass AL, Barnard J, Patai BL, Salvi D, Rukstalis DB.
    Cancer Res; 1995 Jul 15; 55(14):3197-203. PubMed ID: 7606741
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 103.